D06597 | |
D number | D06597 |
Classification | Drug |
Name | Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
Component | - |
Formula | C23H22F7N4O6P. (C7H17NO5)2 |
Exact mass | 1004.3379 |
Mol weight | 1004.8337 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Cyp inhibitor DG01915 CYP3A5 inhibitor |
Remark | Therapeutic category: 2391 Chemical group: DG02200 |
Activity | - |
Disease | - |
Comment | Active form of prodrug: Aprepitant [DR:D02968] |
Target | TACR1 (NK1R) [HSA:6869] [KO:K04222] |
Metabolism | Enzyme: CYP3A4 [HSA:1576] |
Interaction | CYP inhibition: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP3A7 [HSA:1551] CYP induction: CYP2C9 [HSA:1559] |
Other DBs | CAS: 265121-04-8 PubChem: 47208248 ChEBI: 64311 ChEMBL: CHEMBL1201782 LigandBox: D06597 |
KCF data | - |